Fig. 5: In vivo combined hole/hydrogen therapy performances of the SnS1.68–WO2.41 nanocatalyst. | Nature Communications

Fig. 5: In vivo combined hole/hydrogen therapy performances of the SnS1.68–WO2.41 nanocatalyst.

From: Photocatalysis-mediated drug-free sustainable cancer therapy using nanocatalyst

Fig. 5

The monitoring of 4T1 tumor volume (a), the weight (b) and size (c) of extracted 4T1 tumors after 22-day treatment (n = 5 biologically independent samples), the intratumoral H2, ATP, GSH, and ROS levels (d) before and after NIR irradiation (20 min, 0.5 W/cm2) on nanocatalyst-treated tumor mice (n = 5 biologically independent samples), and the HE stained tumor tissue slices (e). Scale bar, 200 μm. P values were calculated by the two-tailed Student’s t-test (#P = 0.000653, ##P = 0.00007, ###P = 0.000015, ***P < 0.000001; NS, no significant difference). Data are presented as mean values ± SD.

Back to article page